본문 바로가기
KERD
논문KCI 등재후보

Role of home blood pressure monitoring in resistant hypertension

김혜미|신진호
대한고혈압학회 (The Korean Society of Hypertension)|2023.01|Clinical Hypertension|제29권 |pp. 2-2|DOI 10.1186/s40885-022-00226-1

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

Self-monitoringAmbulatory blood pressure monitoringAdherenceResistant hypertensionHome blood pressure monitoringWhitecoat effectPseudoresistance

초록

The definition of resistant hypertension (RHT) has been updated to include failure to achieve target blood pressure (BP) despite treatment with ≥3 antihypertensive drugs, including diuretics, renin-angiotensin system blockers, and calcium channel blockers, prescribed at the maximum or maximally tolerated doses, or as success in achieving the target blood pressure but requiring ≥4 drugs. RHT is a major clinical problem, as it is associated with higher mortality and morbidity than non-RHT. Therefore, it is crucial to accurately identify RHT patients to effectively manage their disease. Out-of-clinic BP measurement, including home BP monitoring and ambulatory BP monitoring is gaining prominence for the diagnosis and management of RHT. Home BP monitoring is advantageous as it is feasibly repetitive, inexpensive, widely available, and because of its reproducibility over long periods. In addition, home BP monitoring has crucial advantage of allowing safe titration for the maximum or maximally tolerable dose, and for self-monitoring, thereby improving clinical inertia and nonadherence, and allowing true RHT to be more accurately identified.

Abstract

The definition of resistant hypertension (RHT) has been updated to include failure to achieve target blood pressure (BP) despite treatment with ≥3 antihypertensive drugs, including diuretics, renin-angiotensin system blockers, and calcium channel blockers, prescribed at the maximum or maximally tolerated doses, or as success in achieving the target blood pressure but requiring ≥4 drugs. RHT is a major clinical problem, as it is associated with higher mortality and morbidity than non-RHT. Therefore, it is crucial to accurately identify RHT patients to effectively manage their disease. Out-of-clinic BP measurement, including home BP monitoring and ambulatory BP monitoring is gaining prominence for the diagnosis and management of RHT. Home BP monitoring is advantageous as it is feasibly repetitive, inexpensive, widely available, and because of its reproducibility over long periods. In addition, home BP monitoring has crucial advantage of allowing safe titration for the maximum or maximally tolerable dose, and for self-monitoring, thereby improving clinical inertia and nonadherence, and allowing true RHT to be more accurately identified.

참고문헌 (61)

  1. Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies", Lancet, 360, pp.1903~1913 (2002)
  2. Roth GA, "Global burden of cardiovascular diseases and risk factors, 1990–2019 : update from the GBD 2019 Study", J Am Coll Cardiol, 76, pp.2982~3021 (2020)
  3. Egan BM, "Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008", Circulation, 124, pp.1046~1058 (2011)
  4. Daugherty SL, "Incidence and prognosis of resistant hypertension in hypertensive patients", Circulation, 125, pp.1635~1642 (2012)
  5. Sim JJ, "Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension", Kidney Int, 88, pp.622~632 (2015)
  6. Williams B, "2018 ESC", ESH guidelines for the management of arterial hypertension, 2018, pp.39, 3021~3104
  7. Hae-Young Lee, "2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension", Clinical Hypertension, 25(4), pp.51~74 (2019), 대한고혈압학회[DOI]
  8. Carey RM, "Resistant Hypertension : detection, evaluation, and management : a scientific statement from the American Heart Association", Hypertension, 72, pp.e53~e90 (2018)
  9. Wei FF, "Diagnosis and management of resistant hypertension : state of the art", Nat Rev Nephrol, 14, pp.428~441 (2018)
  10. Muntner P, "Blood pressure assessment in adults in clinical practice and clinic-based research : JACC scientific expert panel", J Am Coll Cardiol, 73, pp.317~335 (2019)
  11. Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
  12. Persell SD, "Prevalence of resistant hypertension in the United States, 2003–2008", Hypertension, 57, pp.1076~1080 (2011)
  13. Yakovlevitch M, "Resistant hypertension in a tertiary care clinic", Arch Intern Med, 151, pp.1786~1792 (1991)
  14. Garg JP, "Resistant hypertension revisited : a comparison of two universitybased cohorts", Am J Hypertens, 18(5 Pt 1), pp.619~626 (2005)
  15. de la Sierra A, "Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring", Hypertension, 57, pp.898~902 (2011)
  16. Galletti F, "Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers : results from the MINISAL-SIIA study program", J Hum Hypertens, 30, pp.703~708 (2016)
  17. Grigoryan L, "Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence", J Am Soc Hypertens, 7, pp.471~476 (2013)
  18. Judd E, "Apparent and true resistant hypertension : definition, prevalence and outcomes", J Hum Hypertens, 28, pp.463~468 (2014)
  19. Jung O, "Resistant hypertension? Assessment of adherence by toxicological urine analysis", J Hypertens, 31, pp.766~774 (2013)
  20. Brinker S, "Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension", J Am Coll Cardiol, 63, pp.834~835 (2014)
  21. Ceral J, "Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from nonadherence to recommended therapy", Hypertens Res, 34, pp.87~90 (2011)
  22. Gupta P, "Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence", Hypertension, 70, pp.1042~1048 (2017)
  23. Chiu N, "Prevalence, predictors, and outcomes of both true-and pseudo-resistant hypertension in the action to control cardiovascular risk in diabetes trial : a cohort study", Hypertens Res, 44, pp.1471~1482 (2021)
  24. Kumbhani DJ, "Resistant hypertension : a frequent and ominous finding among hypertensive patients with atherothrombosis", Eur Heart J, 34, pp.1204~1214 (2013)
  25. Yoon M, "Prevalence and prognosis of refractory hypertension diagnosed using ambulatory blood pressure measurements", Hypertens Res, 45, pp.1353~1362 (2022)
  26. Smith SM, "Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia : a report from the NHLBI-sponsored WISE Study", J Am Heart Assoc, 3, pp.e000660~ (2014)
  27. Kario K, "Cardiovascular prognosis in drug-resistant hypertension stratified by 24-hour ambulatory blood pressure : the JAMP study", Hypertension, 78, pp.1781~1790 (2021)
  28. Cardoso CR, "Prognostic impact of home blood pressures for adverse cardiovascular outcomes and mortality in patients with resistant hypertension : a prospective cohort study", Hypertension, 78, pp.1617~1627 (2021)
  29. Tsioufis C, "Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity : a 4-year prospective study", J Hypertens, 32, pp.415~422 (2014)
  30. Acelajado MC, "Treatment of resistant and refractory hypertension", Circ Res, 124, pp.1061~1070 (2019)
  31. Bădilă E, "Scafa Udriște A. The road to better management in resistant hypertension-diagnostic and therapeutic insights", Pharmaceutics, 13, pp.714~ (2021)
  32. Imai Y, "The reason why home blood pressure measurements are preferred over clinic or ambulatory blood pressure in Japan", Hypertens Res, 36, pp.661~672 (2013)
  33. O’Brien E, "Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement", J Hypertens, 23, pp.697~701 (2005)
  34. Franklin SS, "The cardiovascular risk of white-coat hypertension", J Am Coll Cardiol, 68, pp.2033~2043 (2016)
  35. Clement DL, "Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension", N Engl J Med, 348, pp.2407~2415 (2003)
  36. Nasothimiou EG, "Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension", Hypertens Res, 35, pp.750~755 (2012)
  37. Nasothimiou EG, "Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension", J Hum Hypertens, 26, pp.696~700 (2012)
  38. Muxfeldt ES, "Is home blood pressure monitoring useful in the management of patients with resistant hypertension?", Am J Hypertens, 28, pp.190~199 (2015)
  39. Hamdidouche I, "Clinic versus ambulatory blood pressure in resistant hypertension : impact of antihypertensive medication nonadherence : a post hoc analysis the DENERHTN study", Hypertension, 74, pp.1096~1103 (2019)
  40. Narita K, "Association of treatment-resistant hypertension defined by home blood pressure monitoring with cardiovascular outcome", Hypertens Res, 45, pp.75~86 (2022)
  41. Barochiner J, "Prognostic value of masked uncontrolled apparent resistant hypertension detected through home blood pressure monitoring", J Hypertens, 39, pp.2141~2146 (2021)
  42. van der Steen MS, "Reproducibility of ambulatory blood pressure monitoring in daily practice", J Hum Hypertens, 13, pp.303~308 (1999)
  43. Palatini P, "Too much of a good thing? A critique of overemphasis on the use of ambulatory blood pressure monitoring in clinical practice", J Hypertens, 20, pp.1917~1923 (2002)
  44. Wizner B, "Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension", J Hypertens, 26, pp.1328~1335 (2008)
  45. Asayama K, "Nocturnal blood pressure measured by home devices : evidence and perspective for clinical application", J Hypertens, 37, pp.905~916 (2019)
  46. Narita K, "Nighttime home blood pressure is associated with the cardiovascular disease events risk in treatment-resistant hypertension", Hypertension, 79, pp.e18~e20 (2022)
  47. Sapina-Beltran E, "Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension", Hypertens Res, 45, pp.436~444 (2022)
  48. Matsui Y, "Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement", Am J Hypertens, 20, pp.385~391 (2007)
  49. Hara A, "Detection of carotid atherosclerosis in individuals with masked hypertension and whitecoat hypertension by self-measured blood pressure at home: the Ohasama study", J Hypertens, 25, pp.321~327 (2007)
  50. Nazarzadeh M, "Resistant hypertension in times of changing definitions and treatment recommendations", Heart, 105, pp.96~97 (2019)
  51. Pickering TG, "Call to action on use and reimbursement for home blood pressure monitoring : executive summary : a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association", Hypertension, 52, pp.1~9 (2008)
  52. Halme L, "Home Measurement of blood pressure study group. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care", Am J Hypertens, 18, pp.1415~1420 (2005)
  53. Cappuccio FP, "Blood pressure control by home monitoring : meta-analysis of randomised trials", BMJ, 329, pp.145~ (2004)
  54. Obara T, "Home blood pressure measurements associated with better blood pressure control : the J-HOME study", J Hum Hypertens, 22, pp.197~204 (2008)
  55. Uhlig K, "Self-measured blood pressure monitoring in the management of hypertension : a systematic review and meta-analysis", Ann Intern Med, 159, pp.185~194 (2013)
  56. Marquez-Contreras E, "Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension : the EAPACUM-HTA study", J Hypertens, 24, pp.169~175 (2006)
  57. Zhang D, "A randomized controlled trial on home blood pressure monitoring and quality of care in stage 2 and 3 hypertension", Hypertens Res, 44, pp.533~540 (2021)
  58. Band R, "Intervention planning for a digital intervention for self-management of hypertension : a theory-, evidence-and person-based approach", Implement Sci, 12, pp.25~ (2017)
  59. Verberk WJ, "Self-measurement of blood pressure at home reduces the need for antihypertensive drugs : a randomized, controlled trial", Hypertension, 50, pp.1019~1025 (2007)
  60. Agarwal R, "Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control : a systematic review and meta-analysis", Hypertension, 57, pp.29~38 (2011)
  61. Omboni S, "Clinical usefulness and cost effectiveness of home blood pressure telemonitoring : meta-analysis of randomized controlled studies", J Hypertens, 31, pp.455~467 (2013)

관련 논문AI추천

When and how to use ambulatory blood pressure monitoring and home blood pressure monitoring for managing hypertensionLee Eun Mi대한고혈압학회 · Clinical Hypertension2024 · 제30권 Resistant hypertension: consensus document from the Korean society of hypertension김광일, 박성하, 신진호, 안신영, 이해영, 임상현, Cho Eun Joo, Kang Hee-Taik, Kim Hack-Lyoung, Kim Hyeon Chang, Kim Ju Han, Kim Woohyeun, Lee Eun Mi, Lee Jang Hoon, Lee Sunki, Park Jong-Moo대한고혈압학회 · Clinical Hypertension2023 · 제29권 Home Blood Pressure Monitoring Has Similar Effects on Office Blood Pressure and Medication Compliance as Usual CareAzlina Ishak, Juliawati Muhammad, Muazah Mat Jamial대한가정의학회 · Korean Journal of Family Medicine2019 · 제40권 제5호Clinical Significance of Home Blood Pressure and Its Possible Practical ApplicationYutaka Imai대한고혈압학회 · Clinical Hypertension2012 · 제18권 제1호Effect of home blood pressure monitoring for blood pressure control in hypertensive patients taking multiple antihypertensive medications including fimasartan (the FORTE study)김광일, 김철호, 최정연대한고혈압학회 · Clinical Hypertension2020 · 제26권 제4호Intensive blood pressure lowering: a practical review편욱범, Camafort Miguel, Coca Antonio, Redón Josep대한고혈압학회 · Clinical Hypertension2020 · 제26권 제4호

이 간행물의 다른 논문 (32건)

Withdrawal of antihypertensaive medication in young to middle-aged adults: a prospective, single-group, intervention study이해영, 이경숙pp. 1-1Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adultsJung Sun Jae, Kim Seung Up, 김현창, 심선영pp. 3-3The association between carbon and nitrogen stable isotope ratios of human hair and hypertensionJong‑Ku Park, 안성복pp. 4-4Fok I and Bsm I gene polymorphism of vitamin D receptor and essential hypertension: a mechanistic linkRajesh Kumar Khare, Priyanka Thapa Manger, Richa Awasthipp. 5-5High blood pressure and associated factors among HIV-infected young persons aged 13 to 25 years at selected health facilities in Rwenzori region, western Uganda, September–October 2021Harris Julie R., Migisha Richard, Ario Alex Riolexus, Kadobera Daniel, Bulage Lilian, Katana Elizabeth, Ndyabakira Alex, Elyanu Peter, Kalamya Julius N.pp. 6-6
원문 보기